Rhine Biotech (002166.SZ): Guangzhou Defu Nutrition will become the company's controlling shareholder and resume trading on December 24

Zhitong Finance App News, Rhine Biotech (002166.SZ) issued an announcement. On December 22, 2025, Guangzhou Telford Nutrition Investment Partnership (limited partnership) (hereinafter referred to as “Guangzhou Telford Nutrition”) and Mr. Qin Benjun, the controlling shareholder and actual controller of the company, signed the “Control Change Framework Agreement”, “Share Transfer Agreement” and “Voting Rights Waiver Agreement”, agreeing that Mr. Qin Benjun will transfer 60 million shares of the company (ratio is 8.09%) to the Guangzhou Telford Nutrition Agreement and waiver of its shares. Right (ratio) 25.50%), retaining voting rights for 22,248,282 shares (3.00% ratio). After the agreed transfer of shares is completed and the board of directors of the listed company is replaced, Guangzhou Defu Nutrition will become the controlling shareholders of the company, and Ms. Hou Ming and Mr. LI ZHENFU (the two parties are husband and wife) will become the joint actual controllers of the company.

In addition, the company plans to purchase 80% of the total shares of Beijing Jinkangpu Food Technology Co., Ltd. (hereinafter referred to as “Beijing Jinkangpu”) from Telford Jinkangpu Holdings Limited Partnership and Xiamen Telford Kimp Investment Partnership (limited partnership) by issuing shares. At the same time, it is planned to raise supporting capital from Guangzhou Defu Nutrition's shares to purchase 15.50% of the shares of natural shareholders Li Yang and Song Jun of Beijing Jinkangpu, to pay intermediary fees, transaction taxes, and supplementary working capital.

The target company is engaged in formulation, production, testing, sales, technological innovation and technical services of food nutritional supplements. Its food nutritional enhancers are widely used in dairy products, energy drinks, food supplements, specialty foods, health food and other fields. The target company is an industry-leading enterprise in the formulation and production of food nutritional supplements, supplying nutritional enhancers to many domestic and foreign infant formula manufacturers.

Through this transaction, the target company will become a holding subsidiary of the listed company. The listed company will expand the industrial chain to the field of nutritional enhancers blending, forming a closed loop in the industrial chain from upstream raw materials to downstream formulation solutions, and achieving business collaboration and upgrading between the listed company and the target company. After the target company was placed in, the listed company's business structure became more diverse, improving the operating stability of the listed company and enhancing its resilience to risks.

Following the company's application to the Shenzhen Stock Exchange, trading of the company's shares will resume when the market opens on December 24, 2025 (Wednesday).